UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Assessment of Subcutaneous vs Intravenous Administration of Anti-PD-1 Antibody PF-06801591 in Patients With Advanced Solid Tumors: A Phase 1 Dose-Escalation Trial

JAMA oncology, 2019-07, Vol.5 (7), p.999

2019

Volltextzugriff (PDF)

Single and multiple ascending-dose study of glucagon-receptor antagonist RN909 in type 2 diabetes: a phase 1, randomized, double-blind, placebo-controlled trial

Endocrine, 2018-11, Vol.62 (2), p.371-380

2018

Volltextzugriff (PDF)

A Phase 1 Dose-Escalation Study of PF-06671008, a Bispecific T-Cell-Engaging Therapy Targeting P-Cadherin in Patients With Advanced Solid Tumors

Frontiers in immunology, 2022-04, Vol.13, p.845417

2022

Volltextzugriff (PDF)

First-in-human study of an OX40 (ivuxolimab) and 4-1BB (utomilumab) agonistic antibody combination in patients with advanced solid tumors

Journal for immunotherapy of cancer, 2022-10, Vol.10 (10), p.e005471

2022

Volltextzugriff (PDF)

ROBUST GLUCOSE AND HBA1C LOWERING AFTER A SINGLE DOSE OF RN909 (PF-06293620) IN TYPE 2 DIABETES (T2D) SUBJECTS

Endocrine practice, 2016-12, Vol.22, p.16

2016

Volltextzugriff (PDF)

Association of Tumor Mutational Burden and Immune Gene Expression with Response to PD-1 Blockade by Sasanlimab Across Tumor Types and Routes of Administration

Targeted oncology, 2021-11, Vol.16 (6), p.773-787

2021

Volltextzugriff (PDF)

Proneurotrophins Require Endocytosis and Intracellular Proteolysis to Induce TrkA Activation

The Journal of biological chemistry, 2008-05, Vol.283 (19), p.12709-12716

2008

Volltextzugriff (PDF)

433 A phase 2 study of evorpacept (ALX148) in combination with pembrolizumab and chemotherapy in patients with advanced head and neck squamous cell carcinoma (HNSCC); ASPEN-04

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A463-A463

2021

Volltextzugriff (PDF)

404 ALX148, a CD47 blocker, in combination with standard chemotherapy and antibody regimens in patients with gastric/gastroesophageal junction (GC) cancer and head and neck squamous cell carcinoma (HNSCC)

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A245-A246

2020

Volltextzugriff (PDF)

498 Evorpacept (ALX148), a CD47 myeloid checkpoint inhibitor, in patients with head and neck squamous cell carcinoma (HNSCC) and with gastric/gastroesophageal cancer (GC); ASPEN-01

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A530-A530

2021

Volltextzugriff (PDF)

P860 Results from a combination of OX40 (PF-04518600) and 4–1BB (utomilumab) agonistic antibodies in melanoma and non-small cell lung cancer in a phase 1 dose expansion cohort

Journal for immunotherapy of cancer, 2020-04, Vol.8 (Suppl 1), p.A9-A10

2020

Volltextzugriff (PDF)

Generation of a high-fidelity antibody against nerve growth factor using library scanning mutagenesis and validation with structures of the initial and optimized Fab-antigen complexes

mAbs, 2014-07, Vol.6 (4), p.1059-1068

2014

Volltextzugriff (PDF)

Appetite enhancement and weight gain by peripheral administration of TrkB agonists in non-human primates

PloS one, 2008-04, Vol.3 (4), p.e1900

2008

Volltextzugriff (PDF)

TrkB and TrkC agonist antibodies improve function, electrophysiologic and pathologic features in Trembler super(J) mice

Experimental neurology, 2010-08, Vol.224 (2), p.495-506

2010

Volltextzugriff (PDF)

Treatment with trkC agonist antibodies delays disease progression in neuromuscular degeneration (nmd) mice

Human molecular genetics, 2005-07, Vol.14 (13), p.1825-1837

2005

Volltextzugriff (PDF)

Macrophage stimulating protein is a target-derived neurotrophic factor for developing sensory and sympathetic neurons

Development (Cambridge), 2003-03, Vol.130 (5), p.995-1002

2003

Volltextzugriff (PDF)

TrkB and TrkC agonist antibodies improve function, electrophysiologic and pathologic features in Trembler J mice

Experimental neurology, 2010-08, Vol.224 (2), p.495-506

2010

Volltextzugriff (PDF)

In vivo survival requirement of a subset of nodose ganglion neurons for nerve growth factor

The European journal of neuroscience, 2000-02, Vol.12 (2), p.670-676

2000

Volltextzugriff (PDF)

Functions of Different Neurotrophic Factors in Regulating Neuronal Survival in the Developing Peripheral Nervous System

gie, Alison Jane

2000

Volltextzugriff (PDF)

The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women’s cancer research organization

International journal of gynecological cancer, 2023-04, Vol.33 (4), p.628-630

2023

Volltextzugriff (PDF)

The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women's cancer research organization

Journal of Gynecologic Oncology, 2023, 34(2), , pp.1-5

2023

Volltextzugriff (PDF)

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

Nature genetics, 2015-04, Vol.47 (4), p.373-380

2015

Volltextzugriff (PDF)

Salt Preference and Ability to Discriminate between Salt Content of Two Commercially Available Products of Australian Primary Schoolchildren

Nutrients, 2019-02, Vol.11 (2), p.388

2019

Volltextzugriff (PDF)

Profiles of Glucose Metabolism in Different Prediabetes Phenotypes, Classified by Fasting Glycemia, 2-Hour OGTT, Glycated Hemoglobin, and 1-Hour OGTT: An IMI DIRECT Study

Diabetes (New York, N.Y.), 2021-09, Vol.70 (9), p.2092-2106

2021

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(34)
Dissertationen
(1)

Sprache

Englisch
(34)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Assessment of Subcutaneous vs Intravenous Administration of Anti-PD-1 Antibody PF-06801591 in Patients With Advanced Solid Tumors: A Phase 1 Dose-Escalation Trial

Single and multiple ascending-dose study of glucagon-receptor antagonist RN909 in type 2 diabetes: a phase 1, randomized, double-blind, placebo-controlled trial

A Phase 1 Dose-Escalation Study of PF-06671008, a Bispecific T-Cell-Engaging Therapy Targeting P-Cadherin in Patients With Advanced Solid Tumors

First-in-human study of an OX40 (ivuxolimab) and 4-1BB (utomilumab) agonistic antibody combination in patients with advanced solid tumors

ROBUST GLUCOSE AND HBA1C LOWERING AFTER A SINGLE DOSE OF RN909 (PF-06293620) IN TYPE 2 DIABETES (T2D) SUBJECTS

Association of Tumor Mutational Burden and Immune Gene Expression with Response to PD-1 Blockade by Sasanlimab Across Tumor Types and Routes of Administration

Proneurotrophins Require Endocytosis and Intracellular Proteolysis to Induce TrkA Activation

433 A phase 2 study of evorpacept (ALX148) in combination with pembrolizumab and chemotherapy in patients with advanced head and neck squamous cell carcinoma (HNSCC); ASPEN-04

404 ALX148, a CD47 blocker, in combination with standard chemotherapy and antibody regimens in patients with gastric/gastroesophageal junction (GC) cancer and head and neck squamous cell carcinoma (HNSCC)

498 Evorpacept (ALX148), a CD47 myeloid checkpoint inhibitor, in patients with head and neck squamous cell carcinoma (HNSCC) and with gastric/gastroesophageal cancer (GC); ASPEN-01

P860 Results from a combination of OX40 (PF-04518600) and 4–1BB (utomilumab) agonistic antibodies in melanoma and non-small cell lung cancer in a phase 1 dose expansion cohort

Generation of a high-fidelity antibody against nerve growth factor using library scanning mutagenesis and validation with structures of the initial and optimized Fab-antigen complexes

Appetite enhancement and weight gain by peripheral administration of TrkB agonists in non-human primates

TrkB and TrkC agonist antibodies improve function, electrophysiologic and pathologic features in Trembler super(J) mice

Treatment with trkC agonist antibodies delays disease progression in neuromuscular degeneration (nmd) mice

Macrophage stimulating protein is a target-derived neurotrophic factor for developing sensory and sympathetic neurons

TrkB and TrkC agonist antibodies improve function, electrophysiologic and pathologic features in Trembler J mice

In vivo survival requirement of a subset of nodose ganglion neurons for nerve growth factor

Functions of Different Neurotrophic Factors in Regulating Neuronal Survival in the Developing Peripheral Nervous System

The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women’s cancer research organization

Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome

The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women's cancer research organization

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

Salt Preference and Ability to Discriminate between Salt Content of Two Commercially Available Products of Australian Primary Schoolchildren

Profiles of Glucose Metabolism in Different Prediabetes Phenotypes, Classified by Fasting Glycemia, 2-Hour OGTT, Glycated Hemoglobin, and 1-Hour OGTT: An IMI DIRECT Study

Suchergebnisse filtern